319 related articles for article (PubMed ID: 22264583)
1. Hepatitis A seroprevalence in children and adolescents aged 1-18 years among a low socioeconomic population in Izmir, Turkey.
Halicioglu O; Akman SA; Tatar B; Atesli R; Kose S
Travel Med Infect Dis; 2012 Jan; 10(1):43-7. PubMed ID: 22264583
[TBL] [Abstract][Full Text] [Related]
2. Changing epidemiology of hepatitis A infection in Izmir, Turkey.
Kurugol Z; Aslan A; Turkoglu E; Koturoglu G
Vaccine; 2011 Aug; 29(37):6259-61. PubMed ID: 21763745
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis A seroprevalence and its relationship with environmental factors in children of different age groups in Kahramanmaras, Eastern Mediterranean region of Turkey.
Kaya D; Guler E; Ekerbicer HC; Dilber C; Karabiber H; Guler S; Davutoglu M; Ciragil P
J Viral Hepat; 2007 Dec; 14(12):830-4. PubMed ID: 18070285
[TBL] [Abstract][Full Text] [Related]
4. Impact of travel on the seroprevalence of hepatitis A in children.
Faillon S; Martinot A; Hau I; Puget A; Moulin F; Noel G; Guen CG; Lorrot M; Callamand P; Hue V; Meritet JF; Gendrel D; Dubos F
J Clin Virol; 2013 Jan; 56(1):46-51. PubMed ID: 23127561
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis a in Lebanon: a changing epidemiological pattern.
Sacy RG; Haddad M; Baasiri G; Khoriati A; Gerbaka BJ; Abu-Elyazeed R
Am J Trop Med Hyg; 2005 Aug; 73(2):453-6. PubMed ID: 16103621
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of hepatitis A virus infection among schoolchildren and adolescents in Kaduna, Nigeria.
Afegbua SL; Bugaje MA; Ahmad AA
Trans R Soc Trop Med Hyg; 2013 Oct; 107(10):627-30. PubMed ID: 23959003
[TBL] [Abstract][Full Text] [Related]
7. Seroepidemiology of hepatitis A among Greek children indicates that the virus is still prevalent: Implications for universal vaccination.
Kyrka A; Tragiannidis A; Cassimos D; Pantelaki K; Tzoufi M; Mavrokosta M; Pedeli X; Athanassiadou F; Hatzimichael A; Konstantopoulos A; Kafetzis D; Papaevangelou V
J Med Virol; 2009 Apr; 81(4):582-7. PubMed ID: 19235841
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hepatitis A antibodies in Eastern Bolivia: a population-based study.
C MA; J M RT; A CR; M BN; M DG; S L MR
J Med Virol; 2013 Oct; 85(10):1692-7. PubMed ID: 23861034
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children.
Al-Aziz AM; Awad MA
East Mediterr Health J; 2008; 14(5):1028-35. PubMed ID: 19161074
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine.
Moisseeva AV; Marichev IL; Biloschitchkay NA; Pavlenko KI; Novik LV; Kovinko LV; Lyabis OI; Houillon G; Rasuli AM
J Viral Hepat; 2008 Oct; 15 Suppl 2():43-6. PubMed ID: 18837833
[TBL] [Abstract][Full Text] [Related]
12. The relation between anti-hepatitis A virus antibodies and residence water access in Rio de Janeiro, Brazil.
Luiz RR; Almeida RM; Almeida RT; de Almeida LM
Int J Hyg Environ Health; 2003 Oct; 206(6):575-82. PubMed ID: 14626904
[TBL] [Abstract][Full Text] [Related]
13. Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India.
Joshi N; Yr NK; Kumar A
Trop Gastroenterol; 2000; 21(2):63-5. PubMed ID: 10881625
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and risk factors of hepatitis A among blood donors in Qazvin, central Iran.
Ramezani H; Bozorgi SH; Nooranipour M; Mostajeri A; Kargar-Fard H; Molaverdikhani S; Mazdaki A; Alavian SM
Singapore Med J; 2011 Feb; 52(2):107-12. PubMed ID: 21373737
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of hepatitis A virus antibody in Bijapur, Karnataka.
Rath CP; Akki A; Patil SV; Kalyanshettar SS
Indian Pediatr; 2011 Jan; 48(1):71-3. PubMed ID: 21317475
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of hepatitis A virus antibodies in Turkish and Moroccan children in Rotterdam.
Richardus JH; Vos D; Veldhuijzen IK; Groen J
J Med Virol; 2004 Feb; 72(2):197-202. PubMed ID: 14695660
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
Jaber SM
Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis A seroprevalence and demographics in Turkish children in Ankara.
Sac RU; Bostanci I; Dallar Y; Cihan G; Atli O
Pediatr Int; 2009 Feb; 51(1):5-8. PubMed ID: 19371270
[TBL] [Abstract][Full Text] [Related]
19. Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: implications for health policy.
Sofian M; Aghakhani A; Farazi AA; Banifazl M; Etemadi G; Azad-Armaki S; Ziazarifi A; Abhari Z; Eslamifar A; Khadem-Sadegh A; Izadi N; Ramezani A
Travel Med Infect Dis; 2010 May; 8(3):176-9. PubMed ID: 20541138
[TBL] [Abstract][Full Text] [Related]
20. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
